UGenome
  • Home
  • About
    • UGenome in the News
    • Team
    • Advisors
    • Partners & Collaborators
    • UGenome’s Mission, Vision, Values
    • Investors
  • Products
    • Medication Response Solutions
    • UGenome’s PGx Case Studies
  • Services
    • Bioinformatics Services
    • Bioinformatics Case Studies
  • Emerging Trends
    • Rare Disease & Women’s Health Resources
    • Blog
    • White Papers & Thought Leadership Articles
  • Contact
Select Page

Pharmacogenomics, Nutrigenomics, and Longevity

by Brooks | Sep 20, 2025 | Emerging Trends, Nutrigenomics, Pharmacogenomics, Precision Health Personalized Medicine

Husna Rahim, PharmD, RPh & Zachary S. Brooks, PhD Integration of pharmacogenomic (PGx) data with nutritional genomics offers promising pathways for extending healthspan and promoting longevity ︎ Clinical implementation guidelines from CPIC and DPWG provide...

Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics

by Brooks | Jul 6, 2025 | Clinical outcomes, Emerging Trends, Next generation sequencing, Pharmacogenomics, Reduce Adverse Drug Reactions

Jennifer Tovar, PharmD & Husna Rahim, PharmD Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics. How has Next Generation Sequencing (NGS) transformed the field of pharmacogenomics (PGx)? NGS, also known as massive parallel sequencing, is...

Pharmacogenomics: Rethinking Mental Health

by Brooks | Jul 6, 2025 | Emerging Trends, Mental Health and Psychiatry, Pharmacogenomics

Jennifer Tovar, PharmD & Hanna M. Schultze, MD, DE, EMBA Pharmacogenomics: Rethinking Mental Health. How might pharmacogenomics (PGx) reshape the treatment paradigm for mental health disorders? Mental health PGx is a rapidly evolving field at the intersection of...

Pharmacogenomics: Ensuring Equitable Benefits for Underserved Patient Populations

by Brooks | Jul 6, 2025 | Emerging Trends, Inequities - Underrepresented, Pharmacogenomics

Zachary Brooks, PhD & Archana Gurudu Pharmacogenomics: Ensuring Equitable Benefits for Underserved Patient Populations. How can pharmacogenomic (PGx) research and testing promote health equity in patients of underserved backgrounds? PGx remains a foundational...

UGenome AI and Kaüna partner to Advance Pharmacogenetics in Kidney Care

by Brooks | Jun 5, 2025 | Kidney-Renal, News, Pharmacogenomics, Transplant

for immediate release June 5, 2025 05:00 a.m. Pacific Standard Time & 8:00 a.m. Eastern Standard Time TUCSON, A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a strategic partnership with Kaüna to deliver medication...

Have YOU EVER WONDERED …why NSAID use in women calls for extra care?

by Brooks | Jun 4, 2025 | Pharmacogenomics, Precision Health Personalized Medicine, Reduce Adverse Drug Reactions, Women's Health, Wondered?

Navya Brinda & Zoe Huestis Have YOU EVER WONDERED …why NSAID use in women calls for extra care? NSAIDs are the most widely used pain and anti-inflammatory medications, with higher usage reported in women than men (Farkouh et al., 2021) Women are twice as...
« Older Entries

Recent Posts

  • Polymorphisms
  • Somatic Variations
  • System Biology
  • Transporters
  • Could Genetic Biomarkers Transform Kidney Disease Treatment?  

Recent Comments

No comments to show.

UGenome Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
About Us

Team

Privacy Policy

Explore

Our Services

Our Products

Partnerships

Resources

Blog

PGx Case Studies

Bioinformatics Case Studies

Emerging Trends

Connect

Contact Us

Join Our LinkedIn

Subscribe to Newsletter